CUSIP: 14757U109
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,388,403
-
Share change
-
+89,821
-
Total reported value
-
$4,231,000
-
Price per share
-
$1.77
-
Number of holders
-
19
-
Value change
-
+$186,322
-
Number of buys
-
6
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP 14757U109:
Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q3 2017
As of 30 Sep 2017,
CASI PHARMACEUTICALS INC - COM (CASI) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,388,403 shares.
The largest 10 holders included
Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, VANGUARD GROUP INC, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, RENAISSANCE TECHNOLOGIES LLC, Raymond James Financial Services Advisors, Inc., Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.